Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals

Journal of Clinical Microbiology

Volumn 49, Issue 8, 2011, Pages 2905-2910

  García Castillo, María ^a   Del Campo, Rosa ^a   Morosini, María Isabel ^a   Riera, Elena ^b   Cabot, Gabriel ^b   Willems, Rob ^c   Van Mansfeld, Rosa ^c   Oliver, Antonio ^b   Cantón, Rafael ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; DORIPENEM; FOSFOMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; NETILMICIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLONE; GENETIC VARIABILITY; HOSPITAL INFECTION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POPULATION DISPERSION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; SPAIN;

ANTI-BACTERIAL AGENTS; CARBAPENEMS; CLUSTER ANALYSIS; CROSS INFECTION; ELECTROPHORESIS, GEL, PULSED-FIELD; GENETIC VARIATION; GENOTYPE; HOSPITALS; HUMANS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; PREVALENCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SPAIN;

PSEUDOMONAS AERUGINOSA;

EID: 79960942259     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00753-11     Document Type: Article

References (37)

1. Baumgart, A. M., M. A. Molinari, and A. C. Silveira. 2010. Prevalence of carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii in high complexity hospital. Braz. J. Infect. Dis. 14:433-436.
2. Bou, R., et al. 2006. Nosocomial outbreak of Pseudomonas aeruginosa infections related to a flexible bronchoscope. J. Hosp. Infect. 64:129-135.
3. Cabot, G., et al. 2011. Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolate from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study. Antimicrob. Agents Chemother. 55:1906-1911.
4. Cantón, R., et al. 2000. Evaluation of the Wider system, a new computer-assisted image-processing device for bacterial identification and susceptibility testing. J. Clin. Microbiol. 38:1339-1346.
5. Carvalho, A. P., et al. 2006. Characterization of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-β- lactamase in a hospital located in Rio de Janeiro, Brazil. Microb. Drug Resist. 12:103-108.
6. Cezário, R. C., et al. 2009. Nosocomial outbreak by imipenem-resistant metallo-β-lactamase-producing Pseudomonas aeruginosa in an adult intensive care unit in a Brazilian teaching hospital. Enferm. Infecc. Microbiol. Clin. 27:269-274.
7. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing; 20th informational supplement. M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA.
8. Curran, B., D. Jonas, H. Grundmann, T. Pitt, and C. G. Dowson. 2004. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J. Clin. Microbiol. 42:5644-5649.
9. Edalucci, E., et al. 2008. Acquisition of different carbapenem resistance mechanisms by an epidemic clonal lineage of Pseudomonas aeruginosa. Clin. Microbiol. Infect. 14:88-90. (Pubitemid 350226577)
10. Elias, J., et al. 2010. Nosocomial outbreak of VIM-2 metallo-β- lactamase producing Pseudomonas aeruginosa associated with retrograde urography. Clin. Microbiol. Infect. 16:1494-1500.
11. Empel, J., et al. 2007. Outbreak of Pseudomonas aeruginosa infections with PER-1 extended-spectrum β-lactamase in Warsaw, Poland: further evidence for an international clonal complex. J. Clin. Microbiol. 45:2829-2834.
12. Gimeno, C., R. Cantón, A. García, M. Gobernado, and Grupo Español de Estudio de Doripenem. 2010. Comparative activity of doripenem, meropenem, and imipenem in recent clinical isolates obtained during the COMPACT-Spain epidemiological surveillance study. Rev. Esp. Quimioter. 23:144-152.
13. Hocquet, D., et al. 2007. Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections. Antimicrob. Agents Chemother. 51:3531-3536.
14. Jolley, K. A., M. S. Chan, and M. C. Maiden. 2004. mlstdbNet - distributed multi-locus sequence typing (MLST) databases. BMC Bioinformatics 5:86.
15. Juan, C., et al. 2005. Contribution of clonal dissemination and selection of mutants during therapy to Pseudomonas aeruginosa antimicrobial resistance in an intensive care unit setting. Clin. Microbiol. Infect. 11:887-892.
16. Juan, C., et al. 2010. Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones. J. Antimicrob. Chemother. 65:474-478.
17. Kikuchi, T., et al. 2007. Contaminated oral intubation equipment associated with an outbreak of carbapenem-resistant Pseudomonas in an intensive care unit. J. Hosp. Infect. 65:54-57. (Pubitemid 44932968)
18. Koh, T. H., et al. 2010. Multilocus sequence types of carbapenem-resistant Pseudomonas aeruginosa in Singapore carrying metallo-β-lactamase genes, including the novel bla(IMP-26) gene. J. Clin. Microbiol. 48:2563-2564.
19. Lanini, S., et al. 2011. Molecular epidemiology of a Pseudomonas aeruginosa hospital outbreak driven by a contaminated disinfectant-soap dispenser. PLoS One 16:e17064.
20. Libisch, B., B. Balogh, and M. Füzi. 2009. Identification of two multidrug-resistant Pseudomonas aeruginosa clonal lineages with a countrywide distribution in Hungary. Curr. Microbiol. 58:111-116.
21. Maiden, M. C., et al. 1998. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc. Natl. Acad. Sci. U. S. A. 95:3140-3145.
22. Nemec, A., L. Krizova, M. Maixnerova, and M. Musilek. 2010. Multidrug-resistant epidemic clones among bloodstream isolates of Pseudomonas aeruginosa in the Czech Republic. Res. Microbiol. 161:234-242.
23. Nordmann, P., et al. 2011. Comparative activity of carbapenem testing: the COMPACT study. J. Antimicrob. Chemother. 66:1070-1078.
24. Peña, C., et al. 2003. An outbreak of carbapenem-resistant Pseudomonas aeruginosa in a urology ward. Clin. Microbiol. Infect. 9:938-943.
25. Peña, C., et al. 2009. Nosocomial outbreak of a non-cefepime-susceptible ceftazidime-susceptible Pseudomonas aeruginosa strain overexpressing MexXY-OprM and producing an integron-borne PSE-1 beta-lactamase. J. Clin. Microbiol. 47:2381-2387.
26. Riera, E., et al. 2011. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem. J. Antimicrob. Chemother. [Epub ahead of print.] doi:10.1093/jac/ dkr232.
27. Rosselló, J., et al. 1992. Investigation of an outbreak of nosocomial infection due to a multiply drug-resistant strain of Pseudomonas aeruginosa. J. Hosp. Infect. 20:87-96.
28. Ryoo, N. H., et al. 2009. Outbreak by meropenem-resistant Pseudomonas aeruginosa producing IMP-6 metallo-β-lactamase in a Korean hospital. Diagn. Microbiol. Infect. Dis. 63:115-117.
29. Sánchez-Carrillo, C., et al. 2009. Contaminated feeding bottles: the source of an outbreak of Pseudomonas aeruginosa infections in a neonatal intensive care unit. Am. J. Infect. Control 37:150-154.
30. Satoh, R., et al. 2008. An outbreak and isolation of drug-resistant Pseudomonas aeruginosa at Niigata University Hospital, Japan. J. Infect. Chemother. 14:325-329.
31. Scheffer, M. C., A. C. Gales, A. L. Barth, J. R. do Carmo Filho, and L. M. Dalla-Costa. 2010. Carbapenem-resistant Pseudomonas aeruginosa: clonal spread in southern Brazil and in the state of Goiás. Braz. J. Infect. Dis. 14:508-509.
32. Tenover, F. C., et al. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
33. van Mansfeld, R., et al. 2009. Pseudomonas aeruginosa genotype prevalence in Dutch cystic fibrosis patients and age dependency of colonization by various P. aeruginosa sequence types. J. Clin. Microbiol. 47:4096-4101.
34. van Mansfeld, R., et al. 2010. The population genetics of Pseudomonas aeruginosa isolates from different patient populations exhibits high-level host specificity. PLoS One 5:e13482.
35. Viedma, E., et al. 2009. Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain. Antimicrob. Agents Chemother. 53:4930-4933.
36. Woodford, N., J. F. Turton, and D. M. Livermore. 9 February 2011. Multi-resistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol. Rev. doi:10.1111/j.1574-6976.2011.00268.x.
37. Zilberberg, M. D., J. Chen, S. H. Mody, A. M. Ramsey, and A. F. Shorr. 2010. Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review. BMC Pulm. Med. 10:45.